<- Go Home

Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Market Cap

EUR 267.4M

Volume

13.4K

Cash and Equivalents

EUR 19.0M

EBITDA

EUR 28.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 57.7M

Profit Margin

23.57%

52 Week High

EUR 33.10

52 Week Low

EUR 16.30

Dividend

N/A

Price / Book Value

1.12

Price / Earnings

-677.05

Price / Tangible Book Value

2.12

Enterprise Value

EUR 348.6M

Enterprise Value / EBITDA

10.91

Operating Income

EUR 16.8M

Return on Equity

0.17%

Return on Assets

2.52

Cash and Short Term Investments

EUR 19.0M

Debt

EUR 100.2M

Equity

EUR 238.4M

Revenue

EUR 244.8M

Unlevered FCF

EUR 30.7M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches